<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 17:18:46" record="41269" source="Espacenet">
	<entities>
		<entity ref="Patent41269" type="Patent">
			<semanticIdentifier>brcris::35349e08c6d1a2f782a17d56fe3c390c</semanticIdentifier>
			<semanticIdentifier>docdb::BR102014022024A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102014022024</semanticIdentifier>
			<semanticIdentifier>docdb::BR102014022024A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20141022024</semanticIdentifier>
			<semanticIdentifier>original::102014022024</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102014022024"/>
			<field name="identifier.lattes" value="7447231140501638"/>
			<field name="identifier.espacenet" value="102014022024"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="composições farmacêuticas antitumorais contendo nanopartículas lipídicas sólidas co-encapsuladas com um composto da classe das antraciclinas e um derivado de vitamina e com atividade antitumoral e uso"/>
			<field name="title.lattes" value="COMPOSIÇÕES FARMACÊUTICAS ANTITUMORAIS CONTENDO NANOPARTÍCULAS LIPÍDICAS SÓLIDAS CO-ENCAPSULADAS COM UM COMPOSTO DA CLASSE DAS ANTRACICLINAS E UM DERIVADO DE VITAMINA E COM ATIVIDADE ANTITUMORAL E USO"/>
			<field name="depositDate" value="2014-09-05"/>
			<field name="publicationDate" value="2016-03-29"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="DAWIDSON ASSIS GOMES"/>
			<field name="inventor" value="LUCAS ANTONIO MIRANDA FERREIRA"/>
			<field name="inventor" value="MARIANA SILVA OLIVEIRA"/>
			<field name="inventor" value="SAMUEL VIDAL MUSSI"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE MINAS GERAIS"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K9/51AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="51AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K31/355AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="355AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61K31/704AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="704AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61K47/44AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="47"/>
				<field name="subgroup" value="44AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="A61P35/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="35"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="abstract.espacenet" value="composições farmacêuticas antitumorais contendo nanopartículas lipídicas sólidas co-encapsuladas com um composto da classe das antraciclinas e um derivado de vitamina e com atividade antitumoral e uso. a presente tecnologia consiste em composições farmacêuticas contendo nanopartículas lipídicas sólidas (nls) co-encapsulando um composto da classe das antraciclinas, preferencialmente a doxorrubicina, e um derivado de vitamina e com atividade antitumoral, preferencialmente o a-succinato de tocoferila, ligados na forma de par iânico, utilizando ou não tgps (succinato de d-alfa tocoferil polietilenoglicol 1000) como agente tensoativo e/ou doador de succinato de tocoferila para o tratamento de tumores sólidos. as nanopartículas apresentam características adequadas para administração intravenosa e elevada citotoxicidade frente às linhagens tumorais, além de promoverem uma liberação controlada do composto da classe das antraciclinas, preferencialmente a doxorrubicina."/>
			<field name="originatesFrom" value="55586908"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102014022024"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102014022024"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102014022024"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20141022024"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102014022024"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person28111" type="Person">
			<semanticIdentifier>lattes::7447231140501638</semanticIdentifier>
			<field name="identifier.lattes" value="7447231140501638"/>
			<field name="name" value="Samuel Vidal Mussi"/>
		</entity>
		<entity ref="OrgUnit21991" type="OrgUnit">
			<semanticIdentifier>brcris::b325025cd443a1ebf025d67185ebad24</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DE MINAS GERAIS"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent41269" toEntityRef="Person28111" type="Inventor"/>
		<relation fromEntityRef="Patent41269" toEntityRef="OrgUnit21991" type="Applicant"/>
	</relations>
</entity-relation-data>
